Published in Br J Ophthalmol on June 01, 2000
Transcription Factors Pax6 and AP-2alpha Interact To Coordinate Corneal Epithelial Repair by Controlling Expression of Matrix Metalloproteinase Gelatinase B. Mol Cell Biol (2004) 1.29
Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome. Br J Ophthalmol (2005) 0.95
Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy. Arch Med Sci (2010) 0.90
Preventive versus treatment effect of AG3340, a potent matrix metalloproteinase inhibitor in a rat model of choroidal neovascularization. J Ocul Pharmacol Ther (2004) 0.87
Polymorphisms in matrix metalloproteinases MMP1 and MMP9 are associated with primary open-angle and angle closure glaucoma in a Pakistani population. Mol Vis (2013) 0.86
Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol (2006) 0.86
Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy. J Cell Commun Signal (2012) 0.79
Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients: MMPs in tear samples from type 1 diabetes. Graefes Arch Clin Exp Ophthalmol (2012) 0.78
Functional and molecular characterization of ex vivo cultured epiretinal membrane cells from human proliferative diabetic retinopathy. Biomed Res Int (2013) 0.78
Effects of doxycycline on intestinal ischemia reperfusion injury induced by abdominal compartment syndrome in a rat model. Curr Ther Res Clin Exp (2010) 0.76
Is granuloma annulare related to intermediate uveitis with retinal vasculitis? Br J Ophthalmol (2003) 0.75
Matrix Metallopeptidase-2 Gene rs2287074 Polymorphism is Associated with Brick Tea Skeletal Fluorosis in Tibetans and Kazaks, China. Sci Rep (2017) 0.75
Effect of bradykinin on TGF-β1-induced retinal pigment epithelial cell proliferation and extracellular matrix secretion. BMC Ophthalmol (2016) 0.75
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature (1997) 10.14
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature (1997) 6.06
Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet (1990) 5.65
Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J (1999) 4.85
Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci U S A (1997) 4.82
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J (1987) 4.56
Age-related macular degeneration. Surv Ophthalmol (1988) 4.18
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol (1997) 4.09
Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell (1998) 3.72
Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology (1996) 3.66
Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet (1994) 3.11
Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol (1998) 3.04
Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell (1998) 2.89
Matrix metalloproteinases: structures, evolution, and diversification. FASEB J (1998) 2.74
Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature (1994) 2.53
A fundus dystrophy with unusual features. Br J Ophthalmol (1949) 2.49
Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol (1998) 2.47
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci (1997) 2.28
Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett (1992) 2.21
Proteolysis and cell migration: creating a path? Curr Opin Cell Biol (1999) 2.19
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature (1997) 2.17
Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest (1989) 2.16
Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol (1992) 2.14
Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol (1999) 2.14
Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci U S A (1996) 2.12
Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett (1998) 2.05
Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem (1994) 1.99
Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis (1998) 1.88
Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol (1993) 1.88
Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci (1994) 1.86
Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J (1997) 1.85
Matrix metalloproteinases in skin. Exp Dermatol (1997) 1.84
Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med (1999) 1.71
Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res (1992) 1.70
Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci (1999) 1.68
TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest Ophthalmol Vis Sci (1999) 1.68
The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells (1997) 1.65
Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol (1993) 1.65
Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest (1994) 1.62
Membrane-type matrix metalloproteinases. APMIS (1999) 1.61
Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology (1999) 1.61
Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem (1999) 1.52
Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol (1996) 1.51
Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest (1998) 1.51
Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nat Genet (1995) 1.50
Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS (1999) 1.49
Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther (1997) 1.47
Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein (1996) 1.45
Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics (1994) 1.44
Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol (1996) 1.44
Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol (1995) 1.43
Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol (1998) 1.39
Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol (1998) 1.38
Complex role of matrix metalloproteinases in angiogenesis. Cell Res (1998) 1.37
MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res (1999) 1.37
Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol (1997) 1.32
Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci (1998) 1.29
Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol (1997) 1.29
Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J Clin Invest (1990) 1.28
Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res (1996) 1.27
Clinical studies with matrix metalloproteinase inhibitors. APMIS (1999) 1.26
Physiological mechanisms for metalloproteinase activation. Matrix Suppl (1992) 1.24
Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. Invest Ophthalmol Vis Sci (1999) 1.24
Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation. J Biol Chem (1998) 1.23
Proteolytic control of growth factor availability. APMIS (1999) 1.21
MMP inhibition in prostate cancer. Ann N Y Acad Sci (1999) 1.21
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. Am J Pathol (1998) 1.20
Metalloproteinases and tissue damage. Br J Rheumatol (1991) 1.18
Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation. APMIS (1999) 1.18
Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp (1998) 1.18
Evaluation of some newer matrix metalloproteinases. Ann N Y Acad Sci (1999) 1.17
Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol (1997) 1.16
Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann N Y Acad Sci (1999) 1.16
Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int J Oncol (1998) 1.16
A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci (1998) 1.15
Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol (1997) 1.15
Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol (1998) 1.14
Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. Invest Ophthalmol Vis Sci (1999) 1.13
Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann N Y Acad Sci (1999) 1.12
A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem Cell Biol (1996) 1.12
Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am J Pathol (1997) 1.10
Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. Invest Ophthalmol Vis Sci (1997) 1.10
Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma. J Pathol (1998) 1.08
Surgery for subfoveal membranes in myopia, angioid streaks, and other disorders. Retina (1995) 1.08
Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. Cardiovasc Res (1999) 1.08
Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost (1998) 1.07
Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. J Cell Biochem (1996) 1.06
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol (1998) 1.05
Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology (1999) 1.04
Matrix metalloproteinase family. Cell Biol Int (1995) 1.03
Matrix metalloproteinases and their inhibitors in human vitreous. Invest Ophthalmol Vis Sci (1998) 1.02
Matrix metalloproteinases and metalloproteinase inhibitors in human interphotoreceptor matrix and vitreous. Curr Eye Res (1998) 1.01
Matrix metalloproteinase inhibition. From the Jurassic to the third millennium. Ann N Y Acad Sci (1999) 1.01
Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol (1999) 1.01
Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor. Arch Ophthalmol (1999) 1.01
An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy. Arch Ophthalmol (1998) 1.01
Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line. Oncogene (1998) 1.00
Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration. Ophthalmology (1994) 1.00
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57
Corticobasal degeneration. Brain (1989) 3.20
Neuronal loss in the frontal cortex in HIV infection. Lancet (1991) 2.71
Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73
Extensive visual loss with topical facial steroids. Eye (Lond) (1993) 1.68
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2007) 1.55
High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ (1998) 1.38
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology (2001) 1.33
Visual acuity and pupillary reactions after peribulbar anaesthesia. Br J Ophthalmol (1994) 1.20
Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol (1998) 1.14
Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. Invest Ophthalmol Vis Sci (1999) 1.14
Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry (1989) 1.14
Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry (1993) 1.09
The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci (1999) 1.09
Understanding and treating depression among cancer patients. Int J Gynecol Cancer (2005) 1.04
Optical coherence tomography and electrophysiology in X-linked juvenile retinoschisis associated with a novel mutation in the XLRS1 gene. Retina (2001) 1.03
Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases. Arch Intern Med (1997) 1.03
TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci (2000) 0.99
Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neurosci Lett (1992) 0.99
Fibrinogen, cholesterol and smoking as risk factors for non-arteritic anterior ischaemic optic neuropathy. Eye (Lond) (1995) 0.98
Correlation of MRI and neuropathology in AIDS. J Neurol Neurosurg Psychiatry (1997) 0.96
Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. Biochem J (1991) 0.94
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2008) 0.93
A prion disease with a novel 96-base pair insertional mutation in the prion protein gene. Neurology (1996) 0.93
An intrinsic dimensionality estimator from near-neighbor information. IEEE Trans Pattern Anal Mach Intell (1979) 0.93
Polar and neutral lipids of pig gingiva. Arch Oral Biol (1971) 0.90
Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus. Vision Res (2002) 0.89
Norrie disease and peripheral venous insufficiency. Br J Ophthalmol (2004) 0.89
Two unusual osteogenic orbital tumors: presumed parosteal osteosarcomas of the orbit. Ophthalmology (2001) 0.88
Beta A4 deposition in the temporal cortex of adults with Down's syndrome. J Neurol Sci (1992) 0.88
Vitreous amyloidosis in alanine 71 transthyretin mutation. Br J Ophthalmol (2005) 0.88
Retained intravitreal lens fragments after phacoemulsification: a clinicopathological correlation. Br J Ophthalmol (1999) 0.88
Multifocal choroiditis: clinicopathologic correlation. Arch Ophthalmol (1998) 0.86
Maintenance of the integrity of the blood-brain barrier in the rat during an in situ saline-based perfusion. Neurosci Lett (1985) 0.85
Differential immunoreactivity of melanocytic lesions of the conjunctiva. Histopathology (2001) 0.85
Antibodies raised against different portions of A4 protein identify a subset of plaques in Down's syndrome. Neurosci Lett (1990) 0.85
Absence of p53 delays apoptotic photoreceptor cell death in the rds mouse. Curr Eye Res (1998) 0.84
Seroprevalence of H5 avian influenza virus in birds in the United Arab Emirates. Vet Rec (2009) 0.83
Progressive dendritic pathology in cynomolgus macaques infected with simian immunodeficiency virus. Neuropathol Appl Neurobiol (1999) 0.83
Oro-pharyngeal protozoa in captive bustards: Clinical and pathological considerations. Avian Pathol (1998) 0.83
Intestinal protozoa and associated bacteria in captive houbara bustards (Chlamydotis undulata) in the United Arab Emirates. Avian Pathol (1999) 0.83
Photoreceptor rescue. Eye (Lond) (1998) 0.82
A morphometric study of the microvasculature of a rat glioma. Neuropathol Appl Neurobiol (1986) 0.82
Hyperosmolar opening of the blood-brain barrier in the energy-depleted rat brain. Part 1. Permeability studies. J Cereb Blood Flow Metab (1988) 0.82
Immunocytochemical characterization of macular hole opercula. Arch Ophthalmol (2001) 0.82
An immunohistochemical study of an autosomal dominant feline rod/cone dysplasia (Rdy cats). Exp Eye Res (1999) 0.82
Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole. Vet Rec (2006) 0.82
Modulation of hydrogen peroxide induced injury to corneal endothelium by virus mediated catalase gene transfer. Br J Ophthalmol (2002) 0.82
Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results. Int Ophthalmol (2001) 0.81
Clinical and pathological features of corticobasal degeneration. Adv Neurol (1990) 0.81
Incorporation of organic tritium (3H) by marine organisms and sediment in the severn estuary/Bristol channel (UK). Mar Pollut Bull (2001) 0.80
Enhancement of tritium concentrations on uptake by marine biota: experience from UK coastal waters. J Radiol Prot (2010) 0.80
Legeais BioKpro III keratoprosthesis implantation: long term results in seven patients. Br J Ophthalmol (2006) 0.80
Measurement of TIMP-3 expression and Bruch's membrane thickness in human macula. Exp Eye Res (2001) 0.80
beta-Amyloid protein load is relatively uniform throughout neocortex and hippocampus in elderly Alzheimer's disease patients. Neurosci Lett (1991) 0.80
Bacterial flora of captive houbara (Chlamydotis undulata), kori (Ardeotis kori) and rufous-crested (Eupodotis ruficrista) bustards. Avian Pathol (1996) 0.79
Long-term results of combined cataract and glaucoma surgery versus trabeculectomy alone in low-risk patients. J Cataract Refract Surg (1996) 0.79
Developmental intestinal aerobic microflora in the kori bustard (Ardeotis kori). Avian Pathol (1998) 0.79
Bacterial flora of the conjunctiva and nasal cavity in normal and diseased captive bustards. Avian Dis (2001) 0.78
Changes in neuron size in cynomolgus macaques infected with various immunodeficiency viruses and poliovirus. Neuropathol Appl Neurobiol (1998) 0.78
An epornitic of avian pox in houbara bustards (Chlamydotis undulata macqueenii). Zentralbl Veterinarmed B (1996) 0.78
Assessment of a commercial sandwich ELISA in the diagnosis of aspergillosis in falcons. Vet Rec (2006) 0.78
The effect of a metabolic inhibitor upon the properties of the cerebral vasculature during a whole-head saline perfusion of the rat. Q J Exp Physiol (1987) 0.78
Minimising the risk of prion transmission by contact tonometry. Br J Ophthalmol (2003) 0.78
Different patterns of neuropathological disease in rhesus monkeys infected by simian immunodeficiency virus, and their relation to the humoral immune response. Neuropathol Appl Neurobiol (1993) 0.77
The effect of a low pH saline perfusate upon the integrity of the energy-depleted rat blood-brain barrier. J Cereb Blood Flow Metab (1989) 0.77
The effect of dexamethasone on vascular permeability of experimental brain tumours. Acta Neuropathol (1986) 0.77
Peptidergic hormones and neuropeptides, and aminergic neurotransmitters of the pancreatic islets of the Houbara bustard (Chlamydotis undulata). J Anat (2000) 0.77
Serum bile acids in captive bustards. Zentralbl Veterinarmed B (1999) 0.77
Laser photocoagulation alters the pattern of staining for neurotrophin-4, GFAP, and CD68 in human retina. Br J Ophthalmol (2003) 0.76
Humoral response to H5N2 vaccination in exotic birds in the United Arab Emirates. Vet Rec (2007) 0.76
Alzheimer's disease: the relationship between the density of senile plaques, neurofibrillary tangles and A4 protein in human patients. Neurosci Lett (1991) 0.76
Normal blood chemistry of the Houbara bustard (Chlamydotis undulata). Avian Pathol (1996) 0.76
Astrocytosis, beta A4-protein deposition and paired helical filament formation in Alzheimer's disease. J Neurol Sci (1992) 0.76
Glaucoma induced by steroids. BMJ (1994) 0.75
Shaken baby syndrome. Br J Neurosurg (2003) 0.75
Undefined high-power fields. Lancet (1996) 0.75
Effect of steroidal and non-steroidal drugs on the microglia activation pattern and the course of degeneration in the retinal degeneration slow mouse. Ophthalmic Res (2005) 0.75
Haemoproteus in the houbara (Chlamydotis undulata macqueenii) and the rufous-crested bustard (Eupodotis ruficrista) in the United Arab Emirates. Avian Pathol (1996) 0.75
Use of ammonium chloride in falconry in the Middle East. Vet Rec (1995) 0.75
Radiographic analysis of the growth rate of long bones in bustards. Res Vet Sci (2000) 0.75
Radiographic monitoring of the ossification of long bones in kori (Ardeotis kori) and white-bellied (Eupodotis senegalensis) bustards. Res Vet Sci (1999) 0.75
Normal blood chemistry of the kori bustard (Ardeotis kori). Avian Pathol (1996) 0.75
Polysaccharides and the absence of glycogen in the gingiva from normal and diabetic patients. Arch Oral Biol (1970) 0.75
Trichomoniasis in birds of prey (order Falconiformes) in Bahrain. Vet Rec (1995) 0.75
Assessment of seroconversion to a peste des petits ruminants virus live vaccine in Arabian oryx (Oryx leucoryx). Vet Rec (2013) 0.75
Acute phase proteins in three healthy antelope species. Vet Rec (2011) 0.75
Transport of thiamin across the blood-brain barrier of the rat in the absence of aerobic metabolism. Brain Res (1986) 0.75
Parasites of wild houbara bustards in the United Arab Emirates. J Helminthol (1996) 0.75
Pseudomonas aeruginosa infections in kori bustards (Ardeotis kori). Avian Pathol (2000) 0.75
An evaluation of the strontium 85 scan for the detection and localization of bone metastases from prostatic carcinoma: a preliminary report of 93 cases. J Urol (1967) 0.75
Fatty liver syndrome in captive bustards: Clinical, pathological and epidemiological findings. Avian Pathol (1997) 0.75
Recurrent ptosis due to myopathy of the levator palpebrae superioris. J Neurol Neurosurg Psychiatry (2010) 0.75
Ophthalmologists' perspective. Methods Mol Med (2001) 0.75
Temporal assessment of seroconversion in response to inactivated foot-and-mouth disease vaccine in Arabian oryx (Oryx leucoryx). Vet Rec (2008) 0.75
Vascular chorea: case report with pathology. Mov Disord (1994) 0.75